AbbVie Inc.
ABBV
$210.75
-$0.79-0.37%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -101.41% | 13.94% | 0.07% | 66.55% | -53.77% |
| Total Depreciation and Amortization | 1.11% | -2.44% | 2.75% | -0.10% | -7.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 407.57% | -50.88% | 514.86% | -75.21% | 51.18% |
| Change in Net Operating Assets | -152.93% | 122.18% | -1,469.23% | -44.24% | -83.14% |
| Cash from Operations | 29.39% | 139.85% | -43.79% | -15.00% | -37.25% |
| Capital Expenditure | -16.87% | -3.32% | -24.87% | 5.85% | 6.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 78.90% | -907.47% | 91.02% | -1,597.83% | -252.23% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.00% | 2,800.00% | -200.00% | 85.71% | -700.00% |
| Cash from Investing | 77.30% | -649.18% | 88.51% | -1,098.50% | -116.80% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -1,329.78% | 87.96% | 34.46% | -184.73% | -89,600.00% |
| Issuance of Common Stock | -85.07% | 570.00% | -92.13% | 309.68% | -13.89% |
| Repurchase of Common Stock | -2,005.88% | -88.89% | 99.32% | -44,033.33% | 25.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.04% | -0.04% | 0.79% | -5.56% | 0.04% |
| Other Financing Activities | -96.88% | -- | 100.00% | -31.58% | 10.94% |
| Cash from Financing | -123.34% | 49.61% | -156.35% | 343.18% | -67.19% |
| Foreign Exchange rate Adjustments | -675.00% | 188.89% | 50.00% | -178.26% | 243.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.49% | -18.96% | -193.98% | 1,210.57% | -110.45% |
